Skip to main content
SpringerLink
Log in

Febuxostat for hyperuricemia: experience with patients on chronic hemodialysis treatment

  • Letter to the Editor
  • Published:
Clinical and Experimental Nephrology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Hosoya T, Ono I. A repeated oral administration study of febuxostat (TMX-67), a non-purine-selective inhibitor of xanthine oxidase, in patients with impaired renal function in Japan: pharmacokinetic and pharmacodynamic study. J Clin Rheumatol. 2011;17(4 suppl 2):S27–34.

    Google Scholar 

  2. Yamanaka H; Japanese Society of Gout and Nucleic Acid Metabolism. Japanese guideline for the management of hyperuricemia and gout: second edition. Nucleosides Nucleotides Nucleic Acids. 2011;30:1018–29.

    Article  Google Scholar 

  3. El-Zawawy H, Mandell BF. Managing gout: how is it different in patients with chronic kidney disease? Cleve Clin J Med. 2010;77:919–28.

    Article  PubMed  Google Scholar 

  4. Latif W, Karaboyas A, Tong L, Winchester JF, Arrington CJ, Pisoni RL, Marshall MR, Kleophas W, Levin NW, Sen A, Robinson BM, Saran R. Uric acid levels and all-cause and cardiovascular mortality in the hemodialysis population. Clin J Am Soc Nephrol. 2011;6:2470–7.

    Article  PubMed  CAS  Google Scholar 

  5. Tsuda H, Kawada N, Kaimori JY, Kitamura H, Moriyama T, Rakugi H, Takahara S, Isaka Y. Febuxostat suppressed renal ischemia-reperfusion injury via reduced oxidative stress. Biochem Biophys Res Commun. 2012;427:266–72.

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

None declared

Author information

Authors and Affiliations

  1. Division of Nephrology, Department of Internal Medicine, Ibaraki Prefectural Central Hospital, Kasama, Ibaraki, Japan

    Ryoko Horikoshi & Makoto Inoue

  2. Division of Nephrology, Department of Internal Medicine, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke, Tochigi, 329-0498, Japan

    Ryoko Horikoshi, Tetsu Akimoto, Makoto Inoue, Yoshiyuki Morishita & Eiji Kusano

Authors
  1. Ryoko Horikoshi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tetsu Akimoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Makoto Inoue
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yoshiyuki Morishita
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Eiji Kusano
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tetsu Akimoto.

About this article

Cite this article

Horikoshi, R., Akimoto, T., Inoue, M. et al. Febuxostat for hyperuricemia: experience with patients on chronic hemodialysis treatment. Clin Exp Nephrol 17, 149–150 (2013). https://doi.org/10.1007/s10157-012-0763-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10157-012-0763-7

Keywords

Search

Navigation